Temsirolimus and interstitial lung disease Patient Reports February 11, 2012

Temsirolimus Side Effects Report #5807011-X
Temsirolimus side effect was reported by a Physician from EGYPT on July 10, 2008. Male patient, 83 years of age, was diagnosed with renal cell carcinoma and was treated with Temsirolimus. After drug was administered, patient experienced the following side effects: interstitial lung disease, pleural effusion. Temsirolimus dosage: 25 MG/ML EVERY 1 WK. Patient was hospitalized. Patient died on 03/01/2008.

Temsirolimus Side Effects Report #5803559-2
Temsirolimus side effect was reported by a Physician from EGYPT on June 30, 2008. Male patient was diagnosed with renal cell carcinoma and was treated with Temsirolimus. After drug was administered, patient experienced the following side effects: interstitial lung disease, pleural effusion. Temsirolimus dosage: 25 MG/ML EVERY 1 WK. Patient was hospitalized. Patient died on 02/01/2008.

Temsirolimus Side Effects Report #5805413-9
Temsirolimus side effect was reported by a Physician from EGYPT on June 30, 2008. Male patient was diagnosed with renal cell carcinoma and was treated with Temsirolimus. After drug was administered, patient experienced the following side effects: interstitial lung disease, pleural effusion. Temsirolimus dosage: 25 MG/ML EVERY 1 WK. Patient was hospitalized. Patient died on 03/01/2008.

Temsirolimus Side Effects Report #5815314-8
Temsirolimus side effect was reported by a Physician from EGYPT on July 10, 2008. Male patient was diagnosed with renal cell carcinoma and was treated with Temsirolimus. After drug was administered, patient experienced the following side effects: interstitial lung disease, pleural effusion. Temsirolimus dosage: 25 MG/ML EVERY 1 WK. During the same period patient was treated with CIPRALEX, LYRICA, TARGOCID, AVELOX, MAXIPIME, ROCEPHIN, BREXIN, TRAMAL. Patient was hospitalized. Patient died on 02/01/2008.


Temsirolimus Side Effects Report #6057857-0
Temsirolimus side effect was reported by a Physician from FRANCE on Jan 21, 2009. Male patient, weighting 152.1 lb, was diagnosed with renal cell carcinoma and was treated with Temsirolimus. After drug was administered, patient experienced the following side effects: interstitial lung disease. Temsirolimus dosage: unknown. During the same period patient was treated with GEMFIBROZIL, ACARBOSE, ATENOLOL. Patient was hospitalized. Patient recovered.

Temsirolimus Side Effects Report #6061839-2
Temsirolimus side effect was reported by a Physician from FRANCE on Jan 21, 2009. Male patient, weighting 152.1 lb, was diagnosed with renal cell carcinoma and was treated with Temsirolimus. After drug was administered, patient experienced the following side effects: interstitial lung disease, lung disorder. Temsirolimus dosage: unknown. During the same period patient was treated with GEMFIBROZIL, ACARBOSE, ATENOLOL. Patient was hospitalized. Patient recovered.

Temsirolimus Side Effects Report #5426253-9
Temsirolimus side effect was reported by a Physician from CHINA on Aug 17, 2007. Male patient, weighting 163.1 lb, was diagnosed with mantle cell lymphoma and was treated with Temsirolimus. After drug was administered, patient experienced the following side effects: interstitial lung disease, respiratory failure. Temsirolimus dosage: unknown. Patient was hospitalized. Patient recovered.

Temsirolimus Side Effects Report #5446430-0
Temsirolimus side effect was reported by a Physician from CHINA on Aug 31, 2007. Male patient, weighting 169.8 lb, was diagnosed with mantle cell lymphoma and was treated with Temsirolimus. After drug was administered, patient experienced the following side effects: interstitial lung disease, respiratory failure. Temsirolimus dosage: unknown. Patient was hospitalized. Patient recovered.

Temsirolimus Side Effects Report #5456830-0
Temsirolimus side effect was reported by a Physician from CHINA on Sept 13, 2007. Male patient, weighting 169.8 lb, was diagnosed with mantle cell lymphoma and was treated with Temsirolimus. After drug was administered, patient experienced the following side effects: interstitial lung disease, respiratory failure. Temsirolimus dosage: unknown. Patient was hospitalized. Patient recovered.